FP-045 | Interleukin Related interleukin-related.com

Product Name :
FP-045

Search keywords :
ALDH

drugId :
null

Target Vo:
Aldehyde dehydrogenase

Target Vo Short Name :
ALDH

Moa_Name:
Aldehyde dehydrogenase stimulants

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Foresee Pharmaceuticals Co Ltd

Active Company_Name :
Foresee Pharmaceuticals Co Ltd

Active Indication_Name:
Fanconi Anemia

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Xentuzumab Data Sheet
Setrusumab Cancer
Ctip1 Antibody: Ctip1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 91 kDa, targeting to Ctip1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts